NVE Corp: Form 10-Q for the period ended Jun 30, 2023
Filed with the SEC on Jul 19, 2023 and accepted by EDGAR at Jul 19, 2023, 20:10 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-01 to 2023-06-30 | $8.8m | us-gaap:Revenues |
| Cost of revenue | 3 months2023-04-01 to 2023-06-30 | $2.1m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-04-01 to 2023-06-30 | $6.8m | us-gaap:GrossProfit |
| Research and development | 3 months2023-04-01 to 2023-06-30 | $696.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-04-01 to 2023-06-30 | $5.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-04-01 to 2023-06-30 | $1.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-01 to 2023-06-30 | $4.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-01 to 2023-06-30 | $0.91 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-01 to 2023-06-30 | $0.91 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-01 to 2023-06-30 | 4,840,571 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-04-01 to 2023-06-30 | $5.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-04-01 to 2023-06-30 | $4.1k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2023-04-01 to 2023-06-30 | $4.8m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2023-06-30 | $1.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-06-30 | $26.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-06-30 | $68.1m | us-gaap:Assets |
| Current liabilities | At period end2023-06-30 | $1.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-06-30 | $1.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-06-30 | $66.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001376474-23-000368. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.